FDA Ducks Contempt Claim After Nixing OTC Contraceptives

Law360, New York (December 13, 2011, 7:12 PM EST) -- The U.S. Food and Drug Administration will not face a contempt of court claim after it decided not to allow over-the-counter sales of generic emergency contraceptive drugs to women under 17, a New York federal judge ruled Tuesday.

Reproductive groups, led by the Center for Reproductive Rights, had sought to hold the FDA in contempt after it dragged its feet on a March 2009 court order directing the FDA to reconsider the groups’ petition to allow OTC sales of contraceptive Plan B and its generics to...
To view the full article, register now.




Case Information

Case Title

Tummino et al v. von Eschenbach

Case Number



New York Eastern

Nature of Suit

Other Statutory Actions


Edward R. Korman

Date Filed

January 21, 2005


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.